{
    "@context": {
        "schema": "https://schema.org/",
        "dct": "http://purl.org/dc/terms/",
        "hg": "https://hormuz.group/data/ns#"
    },
    "id": "hg:company:kharazmi-pharmaceutical-company",
    "identifier": "hg:company:kharazmi-pharmaceutical-company",
    "dataset_type": "entity_dataset",
    "entity_type": "company",
    "data_version": "2.0",
    "generated_by": "Hormuz Data Layer 0.2.1",
    "generated_at": "2026-07-04T02:51:17+00:00",
    "name": "Kharazmi Pharmaceutical Company",
    "slug": "kharazmi-pharmaceutical-company",
    "status": "publish",
    "url": "https://hormuz.group/companies/kharazmi-pharmaceutical-company/",
    "json_url": "https://hormuz.group/wp-content/uploads/hormuz-data/cpt/company/kharazmi-pharmaceutical-company.json",
    "rest_url": "https://hormuz.group/wp-json/hormuz-data/v1/cpt/company/kharazmi-pharmaceutical-company",
    "summary": "",
    "machine_summary": "Kharazmi Pharmaceutical Company Kharazmi Pharmaceutical Company is a Tehran-based private pharmaceutical manufacturer with a long operating history and a broad portfolio of oral, topical, pediatric, antibiotic, and general therapeutic products. In the Hormuz Group company graph, it matters because it connects legacy drug manufacturing, private pharmaceutical distribution, common medicine supply, product registration, and potential movement toward more specialized healthcare segments. Kharazmi Pharmaceutical is relevant for investors assessing Iran's private generic-drug manufacturing base, domestic medicine supply, pediatric and oral-dosage demand, distribution-linked business models, and import substitution in active ingredients and packaging. It can support analysis of how older pharmaceutical manufacturers adapt through group structures, distribution arms, and specialty-drug initiatives. Due diligence should verify legal ownership, factory location, product registrations, GMP compliance, sister-company relationships, API sourcing, export markets, distributor dependence, receivables, working capital, and whether any group entity has separate disclosure or financing obligations. Kharazmi Pharmaceutical Company manufactures pharmaceutical products including tablets, capsules, syrups, oral drops, oral antibiotics, creams, sprays, dermatology products, pediatric medicines, gastrointestinal products, respiratory medicines, supplements, and selected specialty pharmaceutical items. Its group links include pharmaceutical distribution, plasma-related activity, oncology-oriented development, and broader healthcare supply functions. province: Tehran industry: Healthcare & Pharma, Manufacturing, Pharmaceuticals market: Consumer Demand, Healthcare, Materials, Supply Chains challenges: Compliance, Import Dependence, Supply Shortage, Technology Gap company_type: Manufacturer city: Tehran",
    "published_at": "2026-06-28T20:28:55+00:00",
    "modified_at": "2026-06-28T20:28:55+00:00",
    "taxonomies": {
        "province": [
            {
                "id": 3,
                "name": "Tehran",
                "slug": "tehran",
                "url": "https://hormuz.group/provinces/tehran/"
            }
        ],
        "industry": [
            {
                "id": 21,
                "name": "Healthcare & Pharma",
                "slug": "healthcare-pharma",
                "url": "https://hormuz.group/industry/healthcare-pharma/"
            },
            {
                "id": 16,
                "name": "Manufacturing",
                "slug": "manufacturing",
                "url": "https://hormuz.group/industry/manufacturing/"
            },
            {
                "id": 121,
                "name": "Pharmaceuticals",
                "slug": "pharmaceuticals",
                "url": "https://hormuz.group/industry/healthcare-pharma/pharmaceuticals/"
            }
        ],
        "market": [
            {
                "id": 34,
                "name": "Consumer Demand",
                "slug": "consumer-demand",
                "url": "https://hormuz.group/market/consumer-demand/"
            },
            {
                "id": 69,
                "name": "Healthcare",
                "slug": "healthcare",
                "url": "https://hormuz.group/market/consumer-demand/healthcare/"
            },
            {
                "id": 73,
                "name": "Materials",
                "slug": "materials",
                "url": "https://hormuz.group/market/enterprise-demand/materials/"
            },
            {
                "id": 76,
                "name": "Supply Chains",
                "slug": "supply-chains",
                "url": "https://hormuz.group/market/enterprise-demand/supply-chains/"
            }
        ],
        "challenges": [
            {
                "id": 164,
                "name": "Compliance",
                "slug": "compliance",
                "url": "https://hormuz.group/challenges/regulatory-barriers/compliance/"
            },
            {
                "id": 176,
                "name": "Import Dependence",
                "slug": "import-dependence",
                "url": "https://hormuz.group/challenges/market-gaps/import-dependence/"
            },
            {
                "id": 177,
                "name": "Supply Shortage",
                "slug": "supply-shortage",
                "url": "https://hormuz.group/challenges/market-gaps/supply-shortage/"
            },
            {
                "id": 179,
                "name": "Technology Gap",
                "slug": "technology-gap",
                "url": "https://hormuz.group/challenges/market-gaps/technology-gap/"
            }
        ],
        "company_type": [
            {
                "id": 299,
                "name": "Manufacturer",
                "slug": "manufacturer",
                "url": "https://hormuz.group/company-type/manufacturer/"
            }
        ],
        "city": [
            {
                "id": 384,
                "name": "Tehran",
                "slug": "tehran",
                "url": "https://hormuz.group/cities/tehran/"
            }
        ]
    },
    "taxonomy_labels": {
        "province": "Tehran",
        "industry": "Healthcare & Pharma, Manufacturing, Pharmaceuticals",
        "market": "Consumer Demand, Healthcare, Materials, Supply Chains",
        "challenges": "Compliance, Import Dependence, Supply Shortage, Technology Gap",
        "company_type": "Manufacturer",
        "city": "Tehran"
    },
    "fields_summary": {
        "legal_name": "Kharazmi Pharmaceutical Company",
        "website": "https://kharazmipharm.com",
        "city": "Tehran, Tehran Province, Iran",
        "ticker_symbol": "",
        "listing_status": "private",
        "products_services": "Kharazmi Pharmaceutical Company manufactures pharmaceutical products including tablets, capsules, syrups, oral drops, oral antibiotics, creams, sprays, dermatology products, pediatric medicines, gastrointestinal products, respiratory medicines, supplements, and selected specialty pharmaceutical items. Its group links include pharmaceutical distribution, plasma-related activity, oncology-oriented development, and broader healthcare supply functions.",
        "export_relevance": "medium",
        "short_profile": "Kharazmi Pharmaceutical Company is a Tehran-based private pharmaceutical manufacturer with a long operating history and a broad portfolio of oral, topical, pediatric, antibiotic, and general therapeutic products. In the Hormuz Group company graph, it matters because it connects legacy drug manufacturing, private pharmaceutical distribution, common medicine supply, product registration, and potential movement toward more specialized healthcare segments.",
        "investment_relevance": "Kharazmi Pharmaceutical is relevant for investors assessing Iran's private generic-drug manufacturing base, domestic medicine supply, pediatric and oral-dosage demand, distribution-linked business models, and import substitution in active ingredients and packaging. It can support analysis of how older pharmaceutical manufacturers adapt through group structures, distribution arms, and specialty-drug initiatives. Due diligence should verify legal ownership, factory location, product registrations, GMP compliance, sister-company relationships, API sourcing, export markets, distributor dependence, receivables, working capital, and whether any group entity has separate disclosure or financing obligations."
    },
    "fields": {
        "rank_math_internal_links_processed": "1",
        "wp_statistics_words_count": "0",
        "legal_name": "Kharazmi Pharmaceutical Company",
        "city": "Tehran, Tehran Province, Iran",
        "ticker_symbol": "",
        "export_relevance": "medium",
        "verification_status": "basic",
        "data_confidence": "high",
        "listing_status": "private",
        "last_updated": "29/06/2026",
        "website": "https://kharazmipharm.com",
        "products_services": "Kharazmi Pharmaceutical Company manufactures pharmaceutical products including tablets, capsules, syrups, oral drops, oral antibiotics, creams, sprays, dermatology products, pediatric medicines, gastrointestinal products, respiratory medicines, supplements, and selected specialty pharmaceutical items. Its group links include pharmaceutical distribution, plasma-related activity, oncology-oriented development, and broader healthcare supply functions.",
        "short_profile": "Kharazmi Pharmaceutical Company is a Tehran-based private pharmaceutical manufacturer with a long operating history and a broad portfolio of oral, topical, pediatric, antibiotic, and general therapeutic products. In the Hormuz Group company graph, it matters because it connects legacy drug manufacturing, private pharmaceutical distribution, common medicine supply, product registration, and potential movement toward more specialized healthcare segments.",
        "investment_relevance": "Kharazmi Pharmaceutical is relevant for investors assessing Iran's private generic-drug manufacturing base, domestic medicine supply, pediatric and oral-dosage demand, distribution-linked business models, and import substitution in active ingredients and packaging. It can support analysis of how older pharmaceutical manufacturers adapt through group structures, distribution arms, and specialty-drug initiatives. Due diligence should verify legal ownership, factory location, product registrations, GMP compliance, sister-company relationships, API sourcing, export markets, distributor dependence, receivables, working capital, and whether any group entity has separate disclosure or financing obligations.",
        "source_note": "Based on public company, official-company, pharmaceutical-sector, product, registry, distribution, and market-related information. Further verification is required before treating this profile as verified investment intelligence."
    },
    "field_profile": {
        "rank_math_internal_links_processed": {
            "type": "string",
            "present": true,
            "length": 1
        },
        "wp_statistics_words_count": {
            "type": "string",
            "present": true,
            "length": 1
        },
        "legal_name": {
            "type": "string",
            "present": true,
            "length": 31
        },
        "city": {
            "type": "string",
            "present": true,
            "length": 29
        },
        "ticker_symbol": {
            "type": "string",
            "present": false,
            "length": 0
        },
        "export_relevance": {
            "type": "string",
            "present": true,
            "length": 6
        },
        "verification_status": {
            "type": "string",
            "present": true,
            "length": 5
        },
        "data_confidence": {
            "type": "string",
            "present": true,
            "length": 4
        },
        "listing_status": {
            "type": "string",
            "present": true,
            "length": 7
        },
        "last_updated": {
            "type": "string",
            "present": true,
            "length": 10
        },
        "website": {
            "type": "string",
            "present": true,
            "length": 25
        },
        "products_services": {
            "type": "string",
            "present": true,
            "length": 452
        },
        "short_profile": {
            "type": "string",
            "present": true,
            "length": 456
        },
        "investment_relevance": {
            "type": "string",
            "present": true,
            "length": 709
        },
        "source_note": {
            "type": "string",
            "present": true,
            "length": 229
        }
    },
    "sources": [
        {
            "type": "note",
            "value": "Based on public company, official-company, pharmaceutical-sector, product, registry, distribution, and market-related information. Further verification is required before treating this profile as verified investment intelligence."
        }
    ],
    "quality": {
        "required_fields": [
            "legal_name",
            "website",
            "city",
            "listing_status",
            "products_services",
            "export_relevance",
            "verification_status",
            "data_confidence",
            "short_profile",
            "investment_relevance",
            "source_note",
            "last_updated"
        ],
        "missing_required_fields": [],
        "missing_required_count": 0,
        "verification_status": "basic",
        "data_confidence": "high",
        "last_updated": "29/06/2026",
        "stale_over_180_days": false,
        "quality_score": 100
    },
    "verification": {
        "verification_status": "basic",
        "data_confidence": "high",
        "last_updated": "29/06/2026"
    }
}